Capital Bank & Trust CO Becton Dickinson & CO Transaction History

Capital Bank & Trust CO

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$219.9 - $263.41 $54,095 - $64,798	-246 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$195.69 - $279.01 $8,414 - $11,997	43 Added 21.18%	246 $57,000
Q3 2019 Nov 14, 2019	BUY	$230.58 - $256.08 $7,609 - $8,450	33 Added 19.41%	203 $51,000
Q1 2019 May 15, 2019	SELL	$206.05 - $248.17 $4,739 - $5,707	-23 Reduced 11.92%	170 $42,000
Q4 2018 Feb 14, 2019	SELL	$204.73 - $257.93 $5,527 - $6,964	-27 Reduced 12.27%	193 $43,000
Q3 2018 Nov 14, 2018	SELL	$233.07 - $256.0 $34,960 - $38,400	-150 Reduced 40.54%	220 $57,000
Q2 2018 Aug 14, 2018	BUY	$208.1 - $233.85 $50,568 - $56,825	243 Added 191.34%	370 $89,000
Q4 2017 Feb 14, 2018	BUY	$189.0 - $222.64 $24,003 - $28,275	127	127 $27,000

1,737

250M

690K

787K

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $63.9B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

Get notified when there are updates to the investment portfolio of Capital Bank & Trust CO, based on Form 13F filings with the SEC.

Stay updated on Capital Bank & Trust CO with notifications on news.